Evidence map›Paper›PMID 27464501›Full record

ArticleJournal of nanobiotechnology2016

Effect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cells.

Lenka Štefančíková, Sandrine Lacombe, Daniela Salado, Erika Porcel, Eva Pagáčová, Olivier Tillement, François Lux, Daniel Depeš, Stanislav Kozubek, Martin Falk

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 70 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Targeting the organelle for radiosensitization in cancer radiotherapy.Asian journal of pharmaceutical sciences · 2024
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Lenka ŠtefančíkováDepartment of Cell Biology and Radiobiology, Institute of Biophysics of ASCR, Brno, Czech Republic. lenka.stefancikova@u-psud.fr.ORCID http://orcid.org/0000-0003-1644-0353
Sandrine LacombeInstitute des Sciences Moléculaires d'Orsay (ISMO), Université Paris Sud 11, CNRS, Université Paris Saclay, Bât 351, 91405, Orsay Cedex, France.
Daniela SaladoInstitute des Sciences Moléculaires d'Orsay (ISMO), Université Paris Sud 11, CNRS, Université Paris Saclay, Bât 351, 91405, Orsay Cedex, France.
Erika PorcelInstitute des Sciences Moléculaires d'Orsay (ISMO), Université Paris Sud 11, CNRS, Université Paris Saclay, Bât 351, 91405, Orsay Cedex, France.
Eva PagáčováDepartment of Cell Biology and Radiobiology, Institute of Biophysics of ASCR, Brno, Czech Republic.
Olivier TillementInstitut Lumière Matière, Université Claude Bernard Lyon 1, CNRS, 69622, Villeurbanne Cedex, France.
François LuxInstitut Lumière Matière, Université Claude Bernard Lyon 1, CNRS, 69622, Villeurbanne Cedex, France.
Daniel DepešDepartment of Cell Biology and Radiobiology, Institute of Biophysics of ASCR, Brno, Czech Republic.
Stanislav KozubekDepartment of Cell Biology and Radiobiology, Institute of Biophysics of ASCR, Brno, Czech Republic.
Martin FalkDepartment of Cell Biology and Radiobiology, Institute of Biophysics of ASCR, Brno, Czech Republic. falk@ibp.cz.
Czech Academy of Sciences, Institute of Biophysics · CZUniversité Paris-Sud · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTumor targeting of radiotherapy represents a great challenge. The addition of multimodal nanoparticles, such as 3 nm gadolinium-based nanoparticles (GdBNs), has been proposed as a promising strategy to amplify the effects of radiation in tumors and improve diagnostics using the same agents. This singular property named theranostic is a unique advantage of GdBNs. It has been established that the amplification of radiation effects by GdBNs appears due to fast electronic processes. However, the influence of these nanoparticles on cells is not yet understood. In particular, it remains dubious how nanoparticles activated by ionizing radiation interact with cells and their constituents. A crucial question remains open of whether damage to the nucleus is necessary for the radiosensitization exerted by GdBNs (and other nanoparticles).

methodsWe studied the effect of GdBNs on the induction and repair of DNA double-strand breaks (DSBs) in the nuclear DNA of U87 tumor cells irradiated with γ-rays. For this purpose, we used currently the most sensitive method of DSBs detection based on high-resolution confocal fluorescence microscopy coupled with immunodetection of two independent DSBs markers.

resultsWe show that, in the conditions where GdBNs amplify radiation effects, they remain localized in the cytoplasm, i.e. do not penetrate into the nucleus. In addition, the presence of GdBNs in the cytoplasm neither increases induction of DSBs by γ-rays in the nuclear DNA nor affects their consequent repair.

conclusionsOur results suggest that the radiosensitization mediated by GdBNs is a cytoplasmic event that is independent of the nuclear DNA breakage, a phenomenon commonly accepted as the explanation of biological radiation effects. Considering our earlier recognized colocalization of GdBNs with the lysosomes and endosomes, we revolutionary hypothesize here about these organelles as potential targets for (some) nanoparticles. If confirmed, this finding of cytoplasmically determined radiosensitization opens new perspectives of using nano-radioenhancers to improve radiotherapy without escalating the risk of pathologies related to genetic damage.

Indexed as

Cell Line, TumorDNA Breaks, Double-StrandedDNA DamageDNA RepairGadoliniumGlioblastomaHumansMetal NanoparticlesGadoliniumDNA double-strand breaksDNA repairGadoliniumNanomedicineNanoparticlesRadiosensitizationRadiotherapyTheranostic

Identifiers

PMID27464501
PMCPMC4964094
OpenAlexW2486254046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.